Sodium-Glucose Cotransporter-2 Inhibitor Use and Risk of Fournier’s Gangrene: Validating the US Food and Drug Administration Drug Warning (SGLT2i Use and FG Risk)

First published 06/06/2019

Last updated 01/04/2024

EU PAS number:

EUPAS30018

Study

Finalised

Documents

Study protocol

Initial protocol

SGLT2_fournier's_gangrene_study_protocol_20190605_final

English (602.4 KB - PDF) View document

Study results

8. e000985.full (1)

English (1021.88 KB - PDF) View document

Study report

Other information

Publications

Study publications

Secondary tabs